BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Geranylgeranylacetone

geranylgeranylacetone [Supplementary Concept] structure in first source; RN given refers to isomeric cpd without isomeric designation; mixture of (5E,9E,13E) & (5Z,9E,13E)-isomers

183+ PubMed studies analyzed · 8 RCTs · Evidence Score: 40.2

Research Domains

Geranylgeranylacetone has been studied across 24 research domains including 🔬 Oncology, 🔬 Inflammation, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧠 Neuroprotection. The primary research focus is 🔬 Oncology with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Geranylgeranylacetone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Darunavir
3 shared targets
Dodecanol
2 shared targets
methoprene
3 shared targets
Ethanolamine
3 shared targets
Aminopyrine
2 shared targets
Dimethyl
2 shared targets
Dapsone
2 shared targets
Picloram
2 shared targets
Loteprednol
2 shared targets
Farnesol
3 shared targets
Loading evidence profile...

This evidence profile for Geranylgeranylacetone is generated deterministically from 183 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.